BOLD Stock Doubles on Astellas Buyout

Audentes Therapeutics just hit a record high on the M&A news

Digital Content Manager
Dec 3, 2019 at 9:51 AM
facebook X logo linkedin


Gene therapy concern Audentes Therapeutics Inc (NASDAQ:BOLD) has more than doubled this morning, surging 104.9% to trade at $58.63, on news that Japan-based drugmaker Astellas Pharma is set to buy the company in a $3 billion cash deal. BMO and Wedbush both lifted their price targets to the per-share buyout price of $60 in response. 

Meanwhile, Piper Jaffray weighed in to say that the move could mean more M&A is coming for other gene therapy companies, as the large pharma players will be looking to get exposure. The current consensus 12-month price target for BOLD of $51.75 is a slight discount to current levels, and prior to today, 10 of the 13 in coverage called BOLD a "buy" or better. 

In the options pits, traders have been overwhelmingly bullish. During the past 10 weeks, over 28 calls have been bought for every put on the the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) -- a ratio that ranks in the 87th percentile of its annual range. Echoing this, BOLD's Scaheffer's open interest ratio (SOIR) of 0.52 indicates that short-term call options almost double puts among contracts expiring within three months. 

Before today's pop, BOLD was already up 34.2% year-to-date. The equity has been bouncing along atop the $26 region in recent months, but ran straight into resistance at its 80-day moving average during this past week. Today, however, the security burst through this trendline clocking a fresh high right out of the gate. 

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI